Thermo Fisher Scientific (BSP:TMOS34) Beneish M-Score: -2.40 (As of Jun. 25, 2026)


BSP:TMOS34 Thermo Fisher Scientific Inc BSP:TMOS34
74 GF Score
Price R$53.25
GF Value R$63.08
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Thermo Fisher Scientific Beneish M-Score?

Thermo Fisher Scientific BSP:TMOS34 +7.04% 74 Beneish M-Score is -2.40 as of Jun. 25, 2026. GuruFocus rates BSP:TMOS34 with a GF Score™ of 74/100 and a GF Value™ of R$63.08 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 195 Medical Diagnostics & Research companies, Thermo Fisher Scientific ranks worse than 69.74% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.4 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Thermo Fisher Scientific's Beneish M-Score or its related term are showing as below:

BSP:TMOS34' s Beneish M-Score Range Over the Past 10 Years
Min: -2.68   Med: -2.43   Max: -2.03
Current: -2.4

During the past 13 years, the highest Beneish M-Score of Thermo Fisher Scientific was -2.03. The lowest was -2.68. And the median was -2.43.


Thermo Fisher Scientific Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Thermo Fisher Scientific's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thermo Fisher Scientific Beneish M-Score Chart

Thermo Fisher Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.14 -2.46 -2.49 -2.56 -2.43

Thermo Fisher Scientific Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.47 -2.42 -2.41 -2.43 -2.40

BSP:TMOS34 vs DHR, IDXX, A: Beneish M-Score Comparison

For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thermo Fisher Scientific Beneish M-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Thermo Fisher Scientific's Beneish M-Score falls into.


BSP:TMOS34
74GF Score
Thermo Fisher Scientific Inc BSP:TMOS34
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thermo Fisher Scientific Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Thermo Fisher Scientific for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0095+0.528 * 1.014+0.404 * 1.0585+0.892 * 0.9974+0.115 * 1.1204
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9882+4.679 * -0.010231-0.327 * 1.0735
=-2.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was R$56,940 Mil.
Revenue was 57551.748 + 66641.375 + 59647.286 + 60194.113 = R$244,035 Mil.
Gross Profit was 23167.128 + 27338.513 + 24578.629 + 24445.886 = R$99,530 Mil.
Total Current Assets was R$116,704 Mil.
Total Assets was R$592,414 Mil.
Property, Plant and Equipment(Net PPE) was R$55,737 Mil.
Depreciation, Depletion and Amortization(DDA) was R$15,170 Mil.
Selling, General, & Admin. Expense(SGA) was R$47,700 Mil.
Total Current Liabilities was R$76,462 Mil.
Long-Term Debt & Capital Lease Obligation was R$209,555 Mil.
Net Income was 8634.07 + 10714.995 + 8666.608 + 8967.559 = R$36,983 Mil.
Non Operating Income was -303.317 + -218.228 + -734.731 + -560.126 = R$-1,816 Mil.
Cash Flow from Operations was 6233.683 + 18860.355 + 12007.757 + 7758.574 = R$44,860 Mil.
Total Receivables was R$56,550 Mil.
Revenue was 59676.948 + 69520.895 + 58689.604 + 56774.88 = R$244,662 Mil.
Gross Profit was 24385.553 + 29419.022 + 23967.598 + 23413.377 = R$101,186 Mil.
Total Current Assets was R$134,613 Mil.
Total Assets was R$570,288 Mil.
Property, Plant and Equipment(Net PPE) was R$53,729 Mil.
Depreciation, Depletion and Amortization(DDA) was R$16,939 Mil.
Selling, General, & Admin. Expense(SGA) was R$48,394 Mil.
Total Current Liabilities was R$75,857 Mil.
Long-Term Debt & Capital Lease Obligation was R$180,632 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(56939.885 / 244034.522) / (56550.3 / 244662.327)
=0.233327 / 0.231136
=1.0095

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(101185.55 / 244662.327) / (99530.156 / 244034.522)
=0.413572 / 0.407853
=1.014

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (116703.754 + 55737.077) / 592414.318) / (1 - (134612.862 + 53728.831) / 570287.982)
=0.708919 / 0.669743
=1.0585

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=244034.522 / 244662.327
=0.9974

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(16939.241 / (16939.241 + 53728.831)) / (15170.098 / (15170.098 + 55737.077))
=0.239701 / 0.213943
=1.1204

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(47700.382 / 244034.522) / (48394.196 / 244662.327)
=0.195466 / 0.1978
=0.9882

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((209555.302 + 76461.982) / 592414.318) / ((180631.597 + 75857.209) / 570287.982)
=0.482799 / 0.449753
=1.0735

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(36983.232 - -1816.402 - 44860.369) / 592414.318
=-0.010231

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Thermo Fisher Scientific has a M-score of -2.50 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.40 mean?
Thermo Fisher Scientific (BSP:TMOS34) has a Beneish M-Score of -2.40 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Thermo Fisher Scientific and its competitors. According to the industry distribution chart, Thermo Fisher Scientific ranks #136 out of 195 companies in the Medical Diagnostics & Research industry, placing it in the top 69.7%.
Is Thermo Fisher Scientific's Beneish M-Score too high?
Thermo Fisher Scientific's current Beneish M-Score is -2.40. Based on the distribution chart, Thermo Fisher Scientific ranks #136 out of 195 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Thermo Fisher Scientific has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's Beneish M-Score compare to DHR and IDXX?
According to the Medical Diagnostics & Research industry distribution chart, Thermo Fisher Scientific ranks #136 out of 195 companies for Beneish M-Score. This places Thermo Fisher Scientific in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Diagnostics & Research company?
A good Beneish M-Score depends on the Medical Diagnostics & Research industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Thermo Fisher Scientific and its competitors. Thermo Fisher Scientific's current Beneish M-Score is -2.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (BSP:TMOS34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$63.08, compared to a current price of R$53.25 — trading 15.6% below its estimated fair value. The current Beneish M-Score is -2.40. Thermo Fisher Scientific's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Thermo Fisher Scientific (BSP:TMOS34), the current Beneish M-Score is -2.40 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thermo Fisher Scientific (BSP:TMOS34) Overvalued in 2026?

Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be undervalued. The current stock price of R$53.25 is trading 15.6% below its estimated GF Value™ of R$63.08. GuruFocus considers Thermo Fisher Scientific to be Modestly Undervalued.

Key valuation signals for BSP:TMOS34:

  • Beneish M-Score: -2.40
  • GF Value™: R$63.08 vs. price of R$53.25 (15.6% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the BSP:TMOS34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Thermo Fisher Scientific Business Description

Address 168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
74GF Score

Get the complete analysis for BSP:TMOS34

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$53.25
Price
R$63.08
GF Value